Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
636 |
|
| Actual shortage: | 62 (10%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 557 (88%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
20 (29%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2025-07-09 | 2025-08-15 | 262271 |
| LEFLUNOMIDE | 10MG | TABLET | Resolved | 2019-03-29 | 2019-07-06 | 79973 |
| LEFLUNOMIDE | 10MG | TABLET | Resolved | 2023-07-05 | 2023-09-25 | 197620 |
| LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-07-05 | 2023-11-06 | 197624 |
| LETROZOLE | 2.5MG | TABLET | Actual shortage | 2024-03-26 | 2024-12-02 | 223376 |
| LEVETIRACETAM | 250MG | TABLET | Resolved | 2017-10-13 | 2017-11-10 | 25856 |
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2017-10-31 | 2017-11-10 | 27549 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-11-28 | 2017-12-16 | 30910 |
| LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-02-21 | 2018-03-09 | 40452 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2019-05-06 | 2019-06-28 | 83143 |
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-07-18 | 2023-09-25 | 198904 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-07-18 | 2023-08-28 | 198907 |
| LEVETIRACETAM | 500MG | TABLET | Resolved | 2024-01-17 | 2024-04-11 | 216276 |
| LEVETIRACETAM | 250MG | TABLET | Resolved | 2024-01-30 | 2024-03-02 | 217793 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2024-05-28 | 2024-07-18 | 229012 |
| LEVETIRACETAM | 750MG | TABLET | Resolved | 2024-11-25 | 2025-02-11 | 243704 |
| LISINOPRIL (TYPE Z) | 10MG | TABLET | Resolved | 2024-05-28 | 2025-04-08 | 228978 |
| LISINOPRIL (TYPE Z) | 20MG | TABLET | Resolved | 2024-05-28 | 2025-04-01 | 229015 |
| LISINOPRIL (TYPE Z) | 5MG | TABLET | Resolved | 2024-07-03 | 2025-04-08 | 232026 |
| LISINOPRIL/HCTZ (TYPE Z) | 10MG 12.5MG | TABLET | Resolved | 2020-10-20 | 2020-11-19 | 126743 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |